Daily administration of GIP receptor antagonist alleviates glucose intolerance and counters insulin resistance in an animal model of obesity and type 2 diabetes

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)282-282
JournalDiabetologia
Volume47 (S1
Publication statusPublished - 2004

Cite this